Tarsus Pharmaceuticals Inc (NAS:TARS)
$ 64.82 -0.66 (-1.01%) Market Cap: 2.84 Bil Enterprise Value: 2.47 Bil PE Ratio: 0 PB Ratio: 8.11 GF Score: 46/100

Q2 2025 Tarsus Pharmaceuticals Inc Earnings Call Transcript

Aug 6, 2025 / 08:30 PM GMT
Release Date Price: $41.64 (+1.19%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TARS.OQ - Tarsus Pharmaceuticals Inc
Q2 2025 Tarsus Pharmaceuticals Inc Earnings Call
Aug 06, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to TASA's 2nd quarter 2025 earnings conference call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasane, head of investor relations, to lead off the call. David, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Before we begin, I encourage everyone to visit the investors section of the Tarsus website to view the earnings release and related materials we will be discussing today.

Joining me on the call
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot